D32.9

🧬 ICD-10 CM D32.9 — Benign Neoplasm of Meninges, Unspecified

Billable Code Confirmed

ICD-10 CM D32.9 is a valid, fully billable 4-character ICD-10-CM code effective FY2026 (October 1, 2025 through September 30, 2026). The 4th character “9” designates unspecified site within the D32 category, distinguishing this code from [[D32.0]] (cerebral meninges) and D32.1 (spinal meninges), and reflects a deliberate documentation limitation rather than an incomplete code structure — no additional characters are available or required. The ICD-10-CM Tabular List includes “Meningioma NOS” as the single Applicable To term at D32.9, confirming that any meningioma without a documented anatomic site maps here.¹

Non-Billable Parent Codes

D32 (Benign neoplasm of meninges) is the 3-character non-billable category header that cannot be submitted on a claim and will reject on edit. D10-D36 (block) is likewise non-billable. Coders must assign the most specific available 4-character code: D32.0 for cerebral meninges, D32.1 for spinal meninges, or D32.9 only when the anatomic location is genuinely absent from all available documentation after chart review. Defaulting to D32.9 without reviewing imaging reports, operative notes, and discharge summaries constitutes a coding specificity error and is a high-yield CDI gap.

Clinical Context

ICD-10 CMD32.9 captures benign meningeal neoplasms — most commonly meningiomas — when the physician’s documentation, imaging report, surgical note, or pathology report does not specify whether the tumor arises from the cerebral or spinal meninges. In clinical practice, approximately 88-93% of meningiomas are intracranial, meaning the overwhelming majority of D32.9 assignments in a well-coded dataset represent documentation gaps rather than true site uncertainty; D32.9 should function as a CDI trigger before it functions as a final code.^2,3 WHO Grade 1 meningiomas map to D32.x; WHO Grade 2 (atypical) maps to D42.9 (neoplasm of uncertain behavior); WHO Grade 3 (anaplastic/malignant) maps to C70.9 (malignant neoplasm of meninges, unspecified) — behavior classification documented by the treating physician or pathologist governs code selection, not imaging characteristics alone.^2,4

Code Classification

ICD-10 CM D32.9 is an ICD-10-CM diagnosis code classifying a benign neoplasm of the meninges — the three-layered membranous system (dura mater, arachnoid mater, pia mater) that envelops the brain and spinal cord. It is not a procedure code, symptom code, or sign code. D32.9, D42.9, and C70.9 are mutually exclusive behavior classifications for a single meningeal lesion: assigning D32.9 and a D42 or C70 code to the same tumor in the same encounter is a coding error regardless of documentation phrasing.

---

🔍 Code Description

ICD-10 CM D32.9 classifies a benign neoplasm arising from the meninges when the specific meningeal subdivision — cerebral (intracranial) versus spinal — is not identified in the clinical documentation, and the Applicable To term “Meningioma NOS” confirms that any meningioma without a documented anatomic site maps here under the ICD-10-CM Tabular List.¹ The most common neoplasm mapped to this code family is the meningioma, a typically slow-growing, extra-axial tumor arising from arachnoid cap cells of the dura-arachnoid interface; meningiomas account for approximately 36-40% of all primary CNS tumors reported to the CBTRUS and represent the most common benign intracranial neoplasm encountered in adult inpatient neurosurgical admissions.³ Other benign neoplasms included in this code family encompass lipomas, hemangiomas, and fibrous histiocytomas of meningeal tissue origin, though these are substantially less common than meningiomas and typically require pathologic confirmation to distinguish from other extra-axial masses.⁴

Clinically, benign meningeal neoplasms present heterogeneously depending on tumor size, rate of growth, and anatomic location: small tumors are often entirely asymptomatic and discovered incidentally on neuroimaging obtained for unrelated indications, while larger or strategically sited tumors produce progressive headache, focal neurological deficits, cranial nerve palsies, seizures, or obstructive hydrocephalus from mass effect on adjacent eloquent structures.^3,4 The ICD-10-CM convention requires that code assignment follow the documented histologic or clinical behavior classification — a “likely benign” finding on MRI without pathologic confirmation supports D32.9 based on the provider’s clinical impression, but once a pathology report is returned, the histologic grade governs the code family: Grade 1 → D32.x, Grade 2 atypical → D42.9, Grade 3 malignant/anaplastic → C70.9.^1,4 Coders must not upgrade or downgrade the behavior classification based on imaging characteristics when a pathology report is available in the record.

---

🌳 Code Tree / Hierarchy

C00-D49   Chapter 2 — Neoplasms ❌ Non-billable (chapter)
│
├── C70-C72   Malignant neoplasms of brain and other parts of CNS ❌ Non-billable (block)
│   ├── C70.0  Malignant neoplasm of cerebral meninges ✅ Billable
│   ├── C70.1  Malignant neoplasm of spinal meninges ✅ Billable
│   └── C70.9  Malignant neoplasm of meninges, unspecified ✅ Billable
│
├── D10-D36   Benign neoplasms, except benign neuroendocrine tumors ❌ Non-billable (block)
│   │
│   ├── D32     Benign neoplasm of meninges ❌ Non-billable (parent)
│   │   ├── D32.0  Benign neoplasm of cerebral meninges ✅ Billable
│   │   ├── D32.1  Benign neoplasm of spinal meninges ✅ Billable
│   │   └── D32.9  Benign neoplasm of meninges, unspecified ◀ THIS CODE ✅ Billable
│   │
│   ├── D33     Benign neoplasm of brain and other parts of CNS ❌ Non-billable (parent)
│   │   ├── D33.0  Benign neoplasm of brain, supratentorial ✅ Billable
│   │   ├── D33.1  Benign neoplasm of brain, infratentorial ✅ Billable
│   │   ├── D33.2  Benign neoplasm of brain, unspecified ✅ Billable
│   │   ├── D33.3  Benign neoplasm of cranial nerves ✅ Billable
│   │   └── D33.4  Benign neoplasm of spinal cord ✅ Billable
│   │
│   └── D42     Neoplasm of uncertain behavior of meninges ❌ Non-billable (parent)
│       ├── D42.0  Neoplasm of uncertain behavior of cerebral meninges ✅ Billable
│       ├── D42.1  Neoplasm of uncertain behavior of spinal meninges ✅ Billable
│       └── D42.9  Neoplasm of uncertain behavior of meninges, unspecified ✅ Billable

4th Character = Site, Not Laterality

Unlike many ICD-10-CM code families where the 4th or 5th character captures laterality (right/left/bilateral), the D32 family uses the 4th character exclusively for anatomic site: 0 = cerebral, 1 = spinal, 9 = unspecified. There is no right/left axis in the meninges code family — a right convexity meningioma and a left convexity meningioma both map to D32.0. This is a common point of confusion for coders transitioning from other CNS code families that do carry laterality characters.

Behavior Classification Is the Governing Axis

The D32, D42, and C70 families represent mutually exclusive behavior classifications for meningeal neoplasms — they are not a progression hierarchy to be staged over time. Each encounter requires assignment of the code that reflects the currently documented tumor behavior. When a prior encounter used D32.9 and a new biopsy returns WHO Grade 2, the code should be updated to D42.9 for all subsequent encounters; the prior D32.9 code is not retroactively incorrect for the period it was supported, but forward coding must reflect the current documented behavior.

---

✅ Includes

• Meningioma NOS — The ICD-10-CM Tabular List Applicable To note at D32.9 explicitly includes meningioma NOS, confirming that any documented meningioma without a stated anatomic site maps to this code and no further characters are available.¹
• Benign neoplasm of the dura mater, arachnoid, or pia mater, unspecified site — All three meningeal layers are classified under D32.x; when the layer and region are both undocumented, D32.9 applies.¹
• WHO Grade 1 meningioma histologic subtypes, unspecified site — Meningothelial, fibrous, transitional, psammomatous, angiomatous, microcystic, secretory, and lymphoplasmacyte-rich meningioma subtypes are all WHO Grade 1 (benign) and map to D32.9 when site is not specified; the histologic subtype itself does not drive a separate ICD-10-CM code within this family.⁴
• Incidentally discovered benign meningeal mass documented as benign neoplasm, location not stated — When a provider explicitly documents a benign meningeal neoplasm based on imaging characteristics or clinical grounds and no anatomic location is stated anywhere in the available inpatient record, D32.9 is the appropriate principal or secondary diagnosis.¹
• Benign meningeal lipoma, hemangioma, or fibrous histiocytoma of unspecified meningeal site — Non-meningioma benign neoplasms of meningeal tissue origin map to D32.9 when the meningeal site is unspecified.^1,4

---

❌ Excludes

Excludes 1

There are no Excludes 1 notations in the ICD-10-CM Tabular List at the D32 category or D32.9 code level. Excludes 1 restrictions do not apply to this code. When a meningeal neoplasm of uncertain or malignant behavior is documented, a code from the D42 or C70 families must replace D32.9 — these are mutually exclusive behavior classifications for a single lesion, governed by coding convention rather than a formal Excludes 1 annotation at this level.¹

Most Common Classification Error

The most frequent error with D32.9 is assigning it alongside D42.9 or C70.9 for the same lesion in the same encounter — for example, coding D32.9 based on the admission diagnosis and D42.9 when the biopsy result returns during the same stay. When the pathology result arrives before discharge, the final code assignment must reflect the histologic classification; the initial clinical impression code is superseded by the pathologic diagnosis per OG Section II and Section III.¹ Assign the behavior-specific code that best represents the patient’s condition at the time of discharge.

Excludes 2

There are no formal Excludes 2 notations in the ICD-10-CM Tabular List at D32 or D32.9. Coders should note that D42.9, C70.9, D33.0-D33.4, and D33.9 are separately classifiable conditions that may co-exist in the same patient (different lesions, different sites) but require distinct documentation and clinical confirmation before multiple meningeal/CNS neoplasm codes are assigned in a single encounter.¹

---

📋 Clinical Overview

Behavior Classification and Site Specificity — D32.9 vs. D32.0 vs. D32.1

Accurate assignment within the D32 family depends on two documentation elements: (1) confirmed benign behavior (clinical impression or pathologic Grade 1) and (2) documented anatomic site (cerebral/intracranial vs. spinal).^1,4 The site axis is almost always resolvable through chart review — MRI reports routinely identify intracranial versus spinal location, and operative notes specify the surgical approach — making D32.9 a high-yield CDI opportunity in virtually every encounter where it appears as a provisional code. Spinal meningiomas account for approximately 7-12% of all meningiomas, are disproportionately thoracic in location, and carry a strong female predominance; when a coder encounters a thoracic or cervical meningioma in the chart, D32.1 is appropriate and D32.9 is incorrect.^3,4

Feature	D32.9	D32.0	D32.1
Site	Meningeal location genuinely undocumented after full chart review; no imaging, operative, or pathology reference to intracranial or spinal site	Cerebral (intracranial) meninges — convexity, parasagittal, falx, sphenoid wing, olfactory groove, skull base, tentorium, cerebellopontine angle, and all other intracranial meningeal surfaces	Spinal meninges — most commonly thoracic (>80%), followed by cervical; intradural-extramedullary location typical; presents with myelopathy rather than intracranial symptoms
Prevalence in Coded Data	Should be rare in a high-quality coded dataset; frequent D32.9 assignment is a CDI performance metric flag	Most common assignment in the D32 family; approximately 88-93% of meningiomas are intracranial	Less common; female predominance; must be distinguished from D33.4 (spinal cord parenchyma) and extradural spinal masses
Coding Action	Trigger chart review of MRI report, operative note, and discharge summary; initiate CDI query if site is absent from all documentation; D32.9 is appropriate only after exhausting all chart review options	Supported by MRI brain report confirming intracranial location, or operative note documenting craniotomy approach for meningeal tumor; no further specificity available within this code	Requires spinal MRI confirmation documenting intradural-extramedullary meningeal location; verify distinction from D33.4 (cord), D42.1 (uncertain behavior), and extradural lesions

CDI Trigger — Site Specificity

Whenever D32.9 appears in a coding encounter, it should function as an automatic CDI trigger before it functions as a final submitted code. The coder should review the MRI, CT, or operative note for any reference to “intracranial,” “spinal,” “cerebral,” “thoracic,” “cervical,” or anatomic landmarks (parasagittal, convexity, tentorial, foramen magnum, vertebral level) before finalizing D32.9. A concurrent or retrospective provider query is appropriate when documentation is contradictory, absent, or limited to “meningioma” without any anatomic qualifier anywhere in the inpatient record.¹

Manifestations & Symptom Burden

• Headache and signs of increased intracranial pressure — Common presenting symptom in intracranial meningiomas; coded separately only when documented as a distinct clinical management issue not subsumed into routine meningioma care; integral signs and symptoms are not separately coded.¹
• Seizures and epilepsy — Occur in approximately 30% of supratentorial meningiomas; code seizure disorder (G40.89 or appropriate G40 subcategory) separately as an active secondary diagnosis when documented as being managed at the same encounter; seizures carry MCC/CC weight in DRGs 054-055.³
• Focal neurological deficits — Hemiparesis, visual field defects, cranial nerve palsies, or language deficits depending on tumor location; each documented deficit that meets OG Section IV criteria (evaluated, treated, or increases care) should be coded separately as an additional diagnosis.¹
• Obstructive hydrocephalus — Complicates large or strategically positioned meningiomas; G91.1 (obstructive hydrocephalus) or appropriate G91 subcategory carries MCC weight in MDC 01 and represents a key DRG optimization opportunity.¹
• Myelopathy (spinal meningiomas) — Progressive spinal cord compression presenting as weakness, sensory loss, or bowel/bladder dysfunction; paired with D32.1 rather than D32.9 when spinal site is documented; coded separately with the appropriate myelopathy code (G99.2 or G95.19) when documented as an active managed condition.⁴

Manifestation Coding

Per ICD-10-CM Official Guidelines Section I.C.2, signs and symptoms that are integral to the neoplasm (mild incidental headache, expected mass effect) are not separately coded; however, complications and comorbidities that require separate evaluation, management, or increase the level of care — seizure disorder, hydrocephalus, cerebral edema, myelopathy — must be coded as additional diagnoses when documented.¹ Accurate capture of these secondary conditions directly determines DRG tier assignment (MCC vs. without MCC) and represents the single highest-yield CDI opportunity in this DRG family.

---

💰 HCC Risk Adjustment

Component	Detail
HCC Category (V28)	N/A — D32.9 does not map to a CMS-HCC V28 category
RAF Coefficient	None — no risk-score contribution under standard MA V28 model
Risk Adjustment Model	CMS-HCC V28 — 100% operative for Payment Year 2026 (V24 fully retired)
Annual Capture Requirement	Not applicable — no HCC mapping
Payer Implication	No direct MA risk-score impact from D32.9 itself; concurrent diagnoses (seizure disorders, cerebrovascular disease, metabolic conditions) carry independent HCC weight and should be accurately documented and coded
PACE / ESRD Models	Verify separately — HCC mapping may differ from standard MA model; consult model-specific crosswalk files

ICD-10 CM D32.9 does not generate a risk-adjustment coefficient under CMS-HCC V28, which is 100% operative for Payment Year 2026 after the phased 2024-2025 transition period.⁵ The absence of HCC mapping should not discourage accurate documentation and coding — D32.9 supports inpatient admission justification, medical necessity documentation, DRG optimization, and longitudinal clinical record quality regardless of its risk-adjustment value.⁵ Concurrent diagnoses commonly present in meningioma patients — seizure disorders (HCC 83/84 in V28), cerebrovascular disease complications, major metabolic comorbidities — carry their own HCC coefficients and should be accurately documented and captured to reflect full clinical complexity.⁵ Annual verification against published CMS HCC crosswalk files is recommended as code-level mapping is updated with each model recalibration.

---

🏥 MS-DRG Assignment

Component	Value
MDC	MDC 01 — Diseases and Disorders of the Nervous System
DRG with MCC	DRG 054 — Nervous System Neoplasms with MCC
DRG without MCC	DRG 055 — Nervous System Neoplasms without MCC
Tier Structure	2-tier family per MS-DRG v43.0 (no separate CC tier)
Surgical DRG Trigger	ICD-10-PCS OR-procedure codes (craniotomy, laminectomy) shift grouping to surgical DRG clusters with substantially higher relative weights

ICD-10 CM D32.9 as the principal diagnosis sequences to MDC 01 and the 2-tier DRG 054-055 family per MS-DRG v43.0, with final DRG assignment determined by the presence of MCC secondary diagnoses.⁶ Key secondary diagnoses that commonly carry MCC weight in this population include acute cerebral edema (G93.6), obstructive hydrocephalus (G91.1), status epilepticus, respiratory failure, and significant metabolic or cardiovascular comorbidities; CDI review must confirm that all documented complications and comorbidities meeting OG Section IV criteria are captured to support DRG 054 when clinically warranted.⁶ When neurosurgical intervention is performed and ICD-10-PCS OR-procedure codes are assigned (craniotomy codes in the 00B/00T range, laminectomy codes in the 00B/00T spinal range), MS-DRG grouping shifts entirely outside the 054-055 family into the craniotomy DRG cluster (DRGs 023-027) or equivalent spinal procedure DRG cluster, each carrying substantially higher relative weights than the medical neoplasm DRGs.⁶ When D32.9 is not the admitting reason but is identified during the stay as a significant finding requiring evaluation, treatment, or management, OG Section IV governs whether it is assigned as a secondary diagnosis — code it if it affects patient care in terms of requiring clinical evaluation, therapeutic treatment, or extending the stay.¹

---

🔗 Related ICD-10-CM Codes

D32 Family — Site-Specific (Preferred Over D32.9 When Location Is Documented)

Code	Description
D32.0	Benign neoplasm of cerebral meninges — use when intracranial or cerebral location is documented anywhere in the chart; most commonly applicable code in this family
D32.1	Benign neoplasm of spinal meninges — use when spinal location (cervical, thoracic, lumbar, or sacral meninges) is documented

Adjacent CNS Benign and Uncertain-Behavior Codes

Code	Description
D42.0	Neoplasm of uncertain behavior, cerebral meninges — WHO Grade 2 atypical meningioma, intracranial; mutually exclusive with D32.9 for the same lesion
D42.1	Neoplasm of uncertain behavior, spinal meninges — WHO Grade 2 atypical meningioma, spinal; mutually exclusive with D32.9 for the same lesion
D42.9	Neoplasm of uncertain behavior, meninges, unspecified — WHO Grade 2 atypical meningioma, site unspecified; mutually exclusive with D32.9 for the same lesion
C70.9	Malignant neoplasm of meninges, unspecified — WHO Grade 3 anaplastic/malignant meningioma or primary meningeal sarcoma, site unspecified
D33.0	Benign neoplasm of brain, supratentorial — parenchymal origin, not meningeal; distinct from D32.x
D33.1	Benign neoplasm of brain, infratentorial — parenchymal origin; distinguish from posterior fossa meningioma (D32.0)
D33.3	Benign neoplasm of cranial nerves — includes acoustic neuroma/vestibular schwannoma; origin is nerve sheath, not meninges; distinct from D32.x
D33.4	Benign neoplasm of spinal cord — intramedullary parenchymal origin; distinguish carefully from D32.1 (meninges, intradural-extramedullary location)

---

🛠️ Commonly Associated CPT Codes

CPT Code	Description	Billing Notes
61512	Craniectomy, trephination, bone flap craniotomy; for excision of meningioma, supratentorial	Most commonly paired with D32.0 when intracranial site is documented; when D32.9 is assigned and the tumor is intracranial by clinical context, 61512 is appropriate for supratentorial approach; operative note must document meningioma, supratentorial tumor location, and craniotomy/craniectomy technique; laterality modifiers (-RT/-LT) are not standard for craniotomy but anatomic side must be documented.7
61519	Removal of brain tumor, infratentorial or posterior fossa; meningioma	Applied when meningioma is documented in the posterior fossa, cerebellopontine angle, tentorium, or posterior convexity; site documentation in the operative note governs selection between 61512 and 61519 — they are mutually exclusive for a single-tumor, single-session craniotomy, and billing both triggers NCCI bundling edits.7,8
63285	Laminectomy for excision of intraspinal neoplasm; intradural, cervical	Applied when spinal meningioma (intradural-extramedullary) is surgically excised at the cervical level; use 63286 for thoracic and 63287 for thoracolumbar; meningiomas are intradural-extramedullary tumors — confirm location in operative note; typically paired with D32.1 rather than D32.9 when spinal site is documented.7
61796	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion	Reported for Gamma Knife, CyberKnife, or LINAC SRS as definitive or adjuvant treatment for intracranial meningioma; use 61797 for each additional cranial lesion in the same session; not applicable to spinal lesions (use 63620/63621 for spinal SRS); PC/TC split rules apply in facility vs. professional billing contexts.7
70553	MRI brain with and without contrast	Primary imaging modality for meningioma diagnosis, characterization, and surveillance; routinely paired with D32.9 in both inpatient and outpatient encounters for initial workup and follow-up; contrast enhancement is the key imaging feature that characterizes meningioma on MRI and is required for accurate lesion characterization.7

NCCI Bundling Considerations

CPT 61512 and 61519 are mutually exclusive for the same operative session — a single-tumor craniotomy maps to one code based on location; reporting both for a single procedure triggers NCCI bundling edits and constitutes an unbundling violation.⁸ Stereotactic radiosurgery codes (61796/61797) are not bundled with craniotomy codes when SRS is performed as a distinct, separate session (e.g., adjuvant SRS weeks after surgical debulking) — documentation must clearly establish separate session dates and distinct clinical indications to defeat any bundling challenge.⁸ MRI brain (70553) performed on the same date as a craniotomy is typically bundled into the surgical global package and is not separately billable on the operative date unless the imaging is performed for a clearly documented, distinct indication unrelated to surgical planning for the meningioma.⁸

---

🔬 ICD-10-PCS Crosswalk

PCS Code	Full Description	Notes
00B10ZZ	Excision of Cerebral Meninges, Open Approach	Used when partial/subtotal removal of a benign meningeal tumor is performed via open craniotomy; root operation Excision (B) is correct when a portion of the meningeal body part is preserved; the most common PCS assignment for craniotomy-based meningioma surgery; maps with D32.0 as PDx when intracranial site is confirmed, or D32.9 when site is undocumented.9
00T10ZZ	Resection of Cerebral Meninges, Open Approach	Used only when the operative note explicitly documents complete removal of the meningeal body part — an uncommon scenario; root operation Resection (T) requires complete eradication of the target body part, not simply complete tumor resection; confirm with specific operative note language before selecting over 00B10ZZ.9
00BT0ZZ	Excision of Spinal Meninges, Open Approach	Applied when a spinal meningioma is partially excised via open laminectomy approach; typically paired with D32.1 as PDx when spinal site is confirmed; confirm intradural-extramedullary location in operative note to distinguish from extradural lesions which use a different body part value.9
00TT0ZZ	Resection of Spinal Meninges, Open Approach	Used when complete resection of spinal meningeal tissue (as a body part) is documented; requires the same complete-body-part removal standard as 00T10ZZ; substantially less common than 00BT0ZZ for routine spinal meningioma surgery.9

PCS Character Analysis — 00B10ZZ

Position	Character	Value	Definition
1	Section	0	Medical and Surgical — the foundational ICD-10-PCS section encompassing all surgical procedures on defined body parts; the vast majority of meningioma inpatient procedures fall in this section
2	Body System	0	Central Nervous System and Cranial Nerves — encompasses brain, cerebral meninges, spinal meninges, cranial nerves, and spinal cord; both body parts relevant to D32.x (Cerebral Meninges = character 1, Spinal Meninges = character T) are in this body system
3	Root Operation	B	Excision — cutting out or off, without replacement, a portion of a body part; selected when the meningeal body part is not fully removed; the correct root operation for virtually all craniotomy-based meningioma excision because the dura and meninges as a body part remain after tumor removal
4	Body Part	1	Cerebral Meninges — represents the dura mater, arachnoid, and pia mater of the intracranial compartment; use body part T (Spinal Meninges) for 00BT0ZZ and 00TT0ZZ
5	Approach	0	Open — direct visualization via surgical incision and craniotomy; standard for craniotomy-based meningioma excision; percutaneous approach (character 3) would apply to stereotactic biopsy
6	Device	Z	No Device — no implant, graft, drainage device, or other device is placed in the meningeal space as part of this procedure; dural patch closure or cranioplasty uses a separate PCS code
7	Qualifier	Z	No Qualifier — no additional specification; qualifier X (Diagnostic) applies when the procedure is performed solely for diagnostic tissue sampling rather than therapeutic resection

Root Operation: Excision (B) vs. Resection (T)

• Use Excision (B) when the operative note documents partial removal, subtotal resection, near-total resection, gross total resection of the tumor, or debulking — in all of these scenarios, the meningeal body part as a whole remains in place and only the tumor (a portion of the body part) is removed; Excision is the correct default for meningioma surgery and should be selected unless the operative note contains specific language about complete removal of the meningeal body part itself.⁹
• Use Resection (T) only when the operative note explicitly documents complete eradication of the meningeal body part as a whole — language such as “complete dural resection with en bloc meningeal removal” or “total meningectomy” is required; “gross total resection of meningioma” alone does not meet the Resection standard because it refers to the tumor, not the meningeal body part.⁹
• PCS does not recognize laterality modifiers; when bilateral or multiple meningeal tumors are excised in a single session, assign a separate PCS code for each distinct body part treated; within this body system, Cerebral Meninges (1) and Spinal Meninges (T) are distinct body part values, and multiple separate cerebral meningeal lesions excised during the same craniotomy session are still coded with a single 00B10ZZ because they share the same body part.⁹

---

💊 Coding Scenarios and Examples

Scenario 1 — Inpatient Admission for Newly Discovered Meningioma, Observation and Medical Management

Clinical Vignette: A 64-year-old woman is admitted following an emergency department evaluation for new-onset generalized tonic-clonic seizure. Brain MRI with and without contrast demonstrates a 3.5 cm homogeneously enhancing extra-axial mass with broad dural attachment along the right cerebral convexity, imaging characteristics highly consistent with meningioma. Neurosurgery is consulted and documents: “Right convexity meningioma, benign appearance; WHO Grade 1 anticipated. Admit for seizure management and elective surgery planning.” No surgical procedure is performed during the admission. The patient is loaded with levetiracetam, seizure activity resolves, and she is discharged with outpatient neurosurgical follow-up. Pathologic confirmation is not yet available. The discharge summary documents right convexity meningioma as the principal diagnosis and new-onset epilepsy as a secondary diagnosis.

Correct Coding:

• PDx: D32.0 — Benign neoplasm of cerebral meninges; the discharge summary documents intracranial location (right convexity); provider’s clinical documentation of “benign meningioma” supports this code per OG Section II even without pathologic confirmation; D32.9 would be incorrect here because site is explicitly stated.¹
• SDx: G40.89 — Other epilepsy and recurrent seizures; separately coded as an active secondary condition requiring its own clinical management and representing an MCC/CC candidate that may affect DRG tier.¹

CDI Note — D32.9 Would Be an Error Here

This scenario illustrates the most common source of D32.9 overcoding: assigning the unspecified code without reviewing clinical documentation. The physician explicitly documented “right convexity meningioma” — intracranial location is stated, making D32.0 correct. A CDI query is not needed here because location is already in the physician’s own discharge documentation. A coder who assigns D32.9 in this scenario has not completed the required chart review step.

---

Scenario 2 — Inpatient Craniotomy for Meningioma; Documentation Silent on Location

Clinical Vignette: A 55-year-old man is admitted electively for surgical resection of a meningioma diagnosed on outpatient MRI four weeks prior. The admission H&P states “meningioma — scheduled for surgical resection.” The operative note documents: “Craniotomy for excision of meningioma; gross total resection achieved; no intraoperative complications.” The pathology report returns WHO Grade 1 (benign) meningioma. Neither the H&P, the operative note, nor the discharge summary specifies intracranial vs. spinal, right vs. left, or any anatomic location qualifier. The outpatient MRI report is not available in the inpatient chart. The principal discharge diagnosis is documented as: “Meningioma, WHO Grade 1 (benign).” The coder initiates a CDI query but does not receive a response before the billing deadline.

Correct Coding:

• PDx: D32.9 — Benign neoplasm of meninges, unspecified; site is genuinely undocumented in the available inpatient record after full chart review;D32.9 is the appropriate assignment when documentation is silent on location; the pathology result (WHO Grade 1) confirms benign behavior, ruling out D42.9 and C70.9.¹
• Procedure: 00B10ZZ — Excision of Cerebral Meninges, Open Approach; craniotomy operative approach implies intracranial surgery; root operation is Excision (B) per “gross total resection” language (tumor removed, not the meningeal body part as a whole); Open approach (character 0) per craniotomy documentation.⁹

CDI Action Required Before Final Submission

Submitting D32.9 without first exhausting chart review and query options is a coding compliance risk. In this scenario, the outpatient MRI report should be obtained or a physician query initiated before claim submission — “craniotomy” strongly implies intracranial location, and D32.0 is likely correct with a single clarifying query response. If the query cannot be resolved before the billing deadline, D32.9 is the correct default; a retrobilling correction should be initiated when documentation is clarified, as D32.0 is more specific and better reflects the clinical reality of a craniotomy-based procedure.¹

---

Scenario 3 — D32.9 as Secondary Diagnosis; Acute Stroke as Principal Diagnosis

Clinical Vignette: A 70-year-old woman with a documented history of meningioma under surveillance is admitted through the emergency department for acute left MCA territory ischemic stroke confirmed on DWI MRI. The admitting physician documents the meningioma in the active problem list: “Small right sphenoid wing meningioma — stable on serial MRI, WHO Grade 1 confirmed on prior biopsy, no intervention planned at this time.” The patient undergoes IV tPA administration and is monitored in the stroke unit. The meningioma is not treated during this admission. The discharge summary documents principal diagnosis as left MCA ischemic stroke, secondary diagnoses including right sphenoid wing meningioma (benign, WHO Grade 1), essential hypertension, and chronic atrial fibrillation. No neurosurgical procedure is performed.

Correct Coding:

• PDx: I63.512 — Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery; acute stroke is the principal diagnosis (chiefly responsible for admission).¹
• SDx: D32.0 — Benign neoplasm of cerebral meninges; the meningioma is specifically documented as “right sphenoid wing” — an intracranial location — making D32.0 correct; D32.9 would be incorrect because the location is explicitly stated in the discharge summary; even as a secondary diagnosis, the most specific code available must be assigned.¹
• SDx: I10 — Essential (primary) hypertension; documented active comorbidity affecting care.
• SDx: I48.19 — Persistent atrial fibrillation, unspecified; documented active condition; potential CC that may affect stroke DRG tier assignment.

Secondary Diagnosis Assignment

D32.9 would be an error in this scenario for the same reason as Scenario 1 — the physician’s own documentation specifies the anatomic site (right sphenoid wing), making D32.0 the required assignment regardless of whether the meningioma is the principal or a secondary diagnosis. Per OG Section IV, a secondary diagnosis is coded when it affects patient care in terms of requiring clinical evaluation, therapeutic treatment, or extending the length of stay — the attending’s active problem list documentation and the stated clinical management plan (serial MRI surveillance) satisfies this criterion for D32.0 as a secondary code.¹

---

⚠️ Coding Pitfalls and Tips

• Defaulting to D32.9 without chart review: ICD-10 CM D32.9 is the most consistently overcoded ICD-10-CM code in benign meningeal neoplasm encounters. Most operative notes, imaging reports, and discharge summaries identify intracranial vs. spinal location with sufficient specificity to support D32.0 or D32.1 — D32.9 should be assigned only after reviewing all available documentation and finding no site reference whatsoever. Treating D32.9 as a default or shortcut code is a coding error that both understates record quality and creates a signal in audit analytics that CDI processes are not functioning properly in this code family.

• Confusing WHO tumor grade with ICD-10-CM behavior family selection: The three meningeal neoplasm families — D32.x (benign/Grade 1), D42.x (uncertain behavior/Grade 2 atypical), C70.x (malignant/Grade 3 anaplastic) — are mutually exclusive for a single lesion and each requires a different code family. Assigning D32.9 based on a clinical impression of “likely benign” when a pathology report returning WHO Grade 2 is already in the chart is a compliance error — the pathologic result governs when it is available before discharge. Conversely, updating a prior D32.9 to D42.9 or C70.9 mid-stay based on a new biopsy result is correct and required; the code must reflect the patient’s condition at discharge.

• Failing to capture MCC-level secondary diagnoses that drive DRG tier: DRG 054 (with MCC) carries substantially higher relative weight than DRG 055 (without MCC). Common MCCs in meningioma admissions — cerebral edema (G93.6), obstructive hydrocephalus (G91.1), status epilepticus, metabolic encephalopathy — are frequently documented in the clinical notes but absent from the secondary diagnosis list on the face sheet. Every documented, evaluated, and managed comorbidity that meets OG Section IV criteria must be coded; incomplete secondary diagnosis capture is the highest-impact CDI gap in DRGs 054-055 and is directly auditable through retrospective record review.

• Assigning PCS root operation Resection (T) without complete body-part removal documentation: ICD-10-PCS Resection requires complete eradication of the body part. The phrases “gross total resection,” “complete tumor removal,” and “total resection of meningioma” describe complete removal of the tumor mass — not complete removal of the meningeal body part. Unless the operative note documents complete removal of the meninges themselves as a body part (an uncommon neurosurgical scenario), root operation Excision (B) is the correct assignment. Using 00T10ZZ without supporting language creates an inaccurate PCS code that will not withstand payer audit review and distorts surgical case-mix data.

• Using D32.9 as a secondary diagnosis when site is documented for a co-existing meningioma: When D32.9 appears as a secondary diagnosis in an encounter where the physician has documented the anatomic location of the meningioma anywhere in the record — including the problem list, the H&P, prior consult notes, or the discharge summary — the most specific code available must be assigned per OG Section I.A, which requires that codes be assigned to their highest level of specificity. A meningioma listed on the active problem list as “right convexity meningioma” requires D32.0 as the secondary code regardless of whether it was treated during the current admission.

• Omitting a CDI query when D32.9 is the only meningeal code and no imaging or operative documentation is in the inpatient chart: When a patient is discharged with D32.9 as the sole meningeal neoplasm code and no MRI report, operative note, or pathology result in the inpatient record specifies anatomic site, a concurrent or retrospective CDI query is the appropriate next step before finalizing the claim. The Official Guidelines require assignment of the most specific code supported by documentation — a single provider query response confirming intracranial or spinal location elevates D32.9 to D32.0 or D32.1, improving longitudinal data accuracy and supporting payer review without altering the DRG tier in the 054-055 family. Claims submitted with D32.9 when site documentation existed but was not reviewed create audit exposure and retrobilling liability.

---

📚 Sources

¹ ICD-10-CM Official Guidelines for Coding and Reporting, FY2026 (effective October 1, 2025) — Sections I.C.2 (Neoplasm Coding), II (Selection of Principal Diagnosis), III (Reporting Additional Diagnoses — Inpatient), IV (Additional Diagnoses — Outpatient); Centers for Medicare and Medicaid Services and NCHS. ² ICD-10-CM Tabular List of Diseases and Injuries, FY2026 — Category D32, Benign neoplasm of meninges; Applicable To notation at D32.9; NCHS/CDC, effective October 1, 2025. ³ Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. Neuro-Oncology. 2022;24(Suppl 2):v1-v95. ⁴ Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro-Oncology. 2021;23(8):1231-1251. ⁵ CMS-HCC Risk Adjustment Model V28 — ICD-10-CM Crosswalk and Coefficient Files; CMS Office of the Actuary, Payment Year 2026 (100% V28); available at cms.gov/medicare/health-plans/medicareadvtgspecratestats/risk-adjustors. ⁶ CMS IPPS FY2026 Final Rule (CMS-1807-F) — MS-DRG Definitions Manual Version 43.0; MDC 01, DRGs 054-055; CMS, effective October 1, 2025. ⁷ AMA CPT 2025 Professional Edition — Surgery: Nervous System (CPT 61000-64999); CPT 61512, 61519, 61796, 63285-63287, 70553 coding guidance. ⁸ NCCI Policy Manual for Medicare Services, Chapter 9 (Nervous System); CMS 2025-2026 edition; bundling and unbundling rules for craniotomy and radiosurgery codes. ⁹ ICD-10-PCS Official Guidelines for Coding and Reporting, FY2026 — Root operation definitions for Excision (B.3.3) and Resection (B.3.8); CMS, effective October 1, 2025.